NIH-funded research R01 grant

How the brain protein neurexin affects social flexibility and amygdala learning

Official title: Role of neurexin in social adaptation and amygdala plasticity

Funded at Rosalind Franklin Univ of Medicine & Sci · NIH-11300986 · Data updated 2026-11-12

This project looks at whether changes in the ASD-linked gene neurexin alter brain connections that help people change their social behavior.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRosalind Franklin Univ of Medicine & Sci
NIH-funded
Lab location1 site (North Chicago, United States)
Project startAugust 5, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$528,357
NIH project number5R01MH137651-03
Project IDNIH-11300986 on NIH RePORTER

Who could benefit from this research

Could help

People with autism spectrum disorder, especially those known to carry NRXN1 changes or who have trouble adapting social behavior, could be most relevant to the findings.

Less likely to help

Individuals whose autism is unrelated to NRXN1 or whose social challenges stem mainly from non-neural factors may not directly benefit from these results.

What this research studies

From a patient perspective, researchers are using animal models to trace how the ASD-linked gene Nrxn1 (neurexin) affects the brain circuit between the anterior cingulate cortex and basolateral amygdala that helps guide social decisions. They will alter Nrxn1 and measure changes in neural signaling and synaptic plasticity in that circuit. Behavioral tests in rodents will probe social interactions and how well animals adapt when social cues change. The team will combine neural recordings and circuit manipulations to link gene changes to specific brain and behavior differences.

Why it matters

Potential benefit: If successful, this work could reveal how an ASD risk gene leads to social inflexibility and point to new targets for therapies to improve social functioning.

How similar studies have gone: Prior genetic and animal studies have linked NRXN1 to ASD risk, but directly tying NRXN1 to ACC–BLA synaptic plasticity and social adaptability is a newer, less-tested approach.

Where this research is happening

  • Rosalind Franklin Univ of Medicine & Sci
    North Chicago, United States
    Active

Researchers

  • Principal investigator: Rosenkranz, Jeremy E — Rosalind Franklin Univ of Medicine & Sci
  • Study coordinator: Rosenkranz, Jeremy E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.